Skip to content

LeMaitre Vascular LMAT Free cash flow

Free cash flow at other companies

ITG
Integer HoldingsITGR
$737K-87.8%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$24.67M+26.5%
Haemonetics logo
HaemoneticsHAE
$53.28M-47.2%
Abbott logo
AbbottABT
$916M-1.8%
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
$546M
Edwards Lifesciences logo
Edwards LifesciencesEW
-$21.1M-109%

Other financials

Income statement

See full
Revenue$66.6M+11.2%
Gross profit$48.4M+16.8%
Operating income$17.8M+40.8%
Net income$15.7M+42.4%
EPS (diluted)$0.68+41.7%

Balance sheet

See full
Cash & equivalents$26.9M+6.0%
Total debt$20.9M+20.6%
Total equity$406.6M+17.0%
Total assets$629.5M+13.2%

Cash flow

See full
Operating cash flow$15.1M+67.0%
CapEx$2.8M+101%

Valuation

See full
Market cap$2.1B+31.4%
Enterprise value$2.1B+31.6%
P/E33.7×-1.7×
P/S8.2×+1.1×

Profitability

See full
Gross margin72.4%+3.6pp
Operating margin28.5%+5.1pp
Net margin24.3%+4.4pp
FCF margin30.9%+12.7pp

Returns & leverage

See full
Return on equity16.5%+2.8pp
Debt / equity0.1×0.0×
Current ratio14.3×-2.2×

Where this comes from

Calculated from LeMaitre Vascular’s reported figures.

The official record: LeMaitre Vascular’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about LeMaitre Vascular's free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LeMaitre Vascular's free cash flow?
LeMaitre Vascular (LMAT) reported free cash flow of $12.31M in Q1 2026.
How has LeMaitre Vascular's free cash flow changed year-over-year?
LeMaitre Vascular's free cash flow increased by 60.8% year-over-year, from $7.66M to $12.31M.
What is the long-term trend for LeMaitre Vascular's free cash flow?
Over 3 years (2022 to 2025), LeMaitre Vascular's free cash flow has grown at a 49.8% compound annual growth rate (CAGR), from $22.15M to $74.47M.
What does free cash flow mean?
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.